Subsite requirements for peptide aldehyde inhibitors of human calpain I
- 4 March 1997
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 7 (5), 539-544
- https://doi.org/10.1016/s0960-894x(97)00063-2
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Peptidyl aldehyde derivatives as potent and selective inhibitors of cathepsin LBioorganic & Medicinal Chemistry Letters, 1995
- Characterization of a continuous fluorogenic assay for calpain I. Kinetic evaluation of peptide aldehydes, halomethyl ketones and (acyloxy)methyl ketones as inhibitors of the enzymeBioorganic & Medicinal Chemistry Letters, 1995
- Calpain inhibition: an overview of its therapeutic potentialTrends in Pharmacological Sciences, 1994
- Specificity of calcium-activated neutral proteinase (CANP) inhibitors for human ?CANP and mCANPNeurochemical Research, 1993
- Cell-penetrating inhibitors of calpainTrends in Biochemical Sciences, 1991
- Developing selective inhibitors of calpainTrends in Pharmacological Sciences, 1990
- .alpha.-Diketone and .alpha.-keto ester derivatives of N-protected amino acids and peptides as novel inhibitors of cysteine and serine proteinasesJournal of Medicinal Chemistry, 1990
- Inhibitory Effect of di- and Tripeptidyl Aldehydes on Calpains and CathepsinsJournal of Enzyme Inhibition, 1990
- Synthesis of a new cell penetrating calpain inhibitor (calpeptin)Biochemical and Biophysical Research Communications, 1988
- Purification and structure of novel cysteine proteinase inhibitors, staccopins P1 and P2, from Staphylococcus tanabeensis.Agricultural and Biological Chemistry, 1987